α1-Antitrypsin Deficiency Profile

CPT: 81332; 82103
Print Share

Synonyms

  • Alpha1-Antitrypsin Deficiency

Test Includes

α1-Antitrypsin, DNA analysis; α1-antitrypsin, serum; reflex to phenotype


Expected Turnaround Time

6 - 12 days


Specimen Requirements


Specimen

Serum and whole blood


Volume

3 mL serum (1.5 mL in each of two tubes) and 7 mL whole blood


Minimum Volume

1.2 mL serum (0.6 mL in each of two tubes) and 3 mL whole blood (Note: This volume does not allow for repeat testing.)


Container

Red-top tube or gel-barrier tube and lavender-top (EDTA) tube


Storage Instructions

Room temperature


Patient Preparation

Overnight fasting is preferred.


Causes for Rejection

Chylous serum; hemolysis; quantity not sufficient for analysis; improper container; frozen whole blood; buccal swab submitted


Test Details


Limitations

AAT may be elevated into normal range in heterozygous-deficient patients during concurrent infection, pregnancy, estrogen therapy, steroid therapy, cancer, and during postoperative periods. Homozygous-deficient patients will not show such elevation. Normal AAT levels may occur in patients with liver disease who are heterozygotes. In normals, pregnancy and contraceptive medication may elevate levels. Levels are normally low at birth but rise soon thereafter.

Genotyping tests for the two most common mutations, S and Z. Rare alleles, null or otherwise, are not detected by this assay.

α1-antitrypsin therapy may alter the patient phenotype.


Methodology

A1AT Quant: Immunologic; genotype: multiplex allele-specific polymerase chain reaction (PCR) and gel electrophoresis; phenotype: isoelectric focusing (IEF)


References

American Thoracic Society/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Resp Crit Care Med. 2003 Oct 1; 168(7):818-900. 14522813
Buist AS. Alpha 1-antitrypsin deficiency in lung and liver disease. Hosp Pract (Off Ed). 1989 May 15; 24(5):51-59. (review). 2497126
de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 2002 Nov; 122(5):1818-1829. 12426287
Pierce JA. Antitrypsin and Emphysema. Perspective and Prospects. JAMA. 1988 May 20; 259(19):2890-2895. (review). 33285040

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
123260 A1A, Quant+Genotype(Rfx Pheno) 001988 Alpha-1-Antitrypsin, Serum mg/dL 1825-9
123260 A1A, Quant+Genotype(Rfx Pheno) 511883 AAT, DNA Analysis 21723-2
123260 A1A, Quant+Genotype(Rfx Pheno) 511885 Additional Information: 21726-5
123260 A1A, Quant+Genotype(Rfx Pheno) 511884 Electronically Signed by: 72486-4
123260 A1A, Quant+Genotype(Rfx Pheno) 123252 A1A Rfx to Phenotype N/A
Reflex Table for A1A Rfx to Phenotype
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 019292 A1A Phenotype Confirmation 019293 A1A Phenotype Confirmation 6770-2
Reflex Table for A1A Rfx to Phenotype
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 019292 A1A Phenotype Confirmation 019294 Interpretation 32769-2

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf